Cholesteryl ester transfer protein inhibition for preventing cardiovascular events: JACC review topic of the week

Cholesteryl ester transfer protein inhibition for preventing cardiovascular events: JACC review topic of the week

Cholesteryl ester transfer protein (CETP) facilitates exchange of triglycerides and cholesteryl ester between high-density lipoprotein (HDL) and apolipoprotein B100–containing lipoproteins. Evidence from genetic studies that variants in the CETP gene were associated with higher blood HDL cholesterol...

Detaylı Bibliyografya
Asıl Yazarlar:	Armitage, J, Holmes, M, Preiss, D
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Elsevier 2019

Benzer Materyaller

Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart DiseaseNovelty and Significance
Yazar:: Nomura, Akihiro, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

In-silico approach towards identification of inhibitor for cholesteryl ester transfer protein (CETP): A novel strategy
Yazar:: Suraya Abdul Sani, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Artificial intelligence in cardiovascular imaging: JACC state-of-the-art review
Yazar:: Dey, D, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Investigation of the physical properties of cholesteryl ester liquid crystal and the interaction with cells
Yazar:: Wan Omar, Wan Ibtisam
Baskı/Yayın Bilgisi: (2016)

Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar
Yazar:: Preiss, D, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Yazar:: Karpe, F, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Cholesteryl ester transfer protein (CETP)Ile405Val polymorphism affects the rate of fibrosis development in chronic hepatitis C virus infection.
Yazar:: Wright, M, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Development of a novel cell traction force transducer based on cholesteryl ester liquid crystals: characterisation, quantification and evaluation of a cholesteryl ester liquid crystal based single cell force transducer system
Yazar:: Chin, Fhong Soon
Baskı/Yayın Bilgisi: (2011)

Characterization of alginate–gelatin–cholesteryl ester liquid crystals bioinks for extrusion bioprinting of tissue engineering scaffolds
Yazar:: Abdulmaged, Alyaa Idrees, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Synthesis and characterization of a potential alginate-gelatin-cholesteryl ester liquid crystals bioink for tissue engineering applications
Yazar:: Abdulmaged Al-Flayyih, Alyaa Idrees
Baskı/Yayın Bilgisi: (2022)

United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8
Yazar:: Caleyachetty, R, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Yazar:: Sattar, N, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?
Yazar:: Preiss, D, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Yazar:: Price, H, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides modulate CYP2B1 expression in vivo.
Yazar:: Desjardins, J, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis
Yazar:: Kitas, G, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

The role of emerging risk factors in cardiovascular outcome
Yazar:: Lacey, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Fáilte Éireann: two weeks of Irish events
Yazar:: Brent Council, BC

Topical repellents for malaria prevention
Yazar:: Gabaldón Figueira, JC, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Topical repellents for malaria prevention
Yazar:: Wagah, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Cholesterol- and blood pressure-lowering drug use for secondary cardiovascular prevention in 2004 - 2013 Europe
Yazar:: Achelrod, D, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
Yazar:: Mwinga, A, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017
Yazar:: Thalmann, I, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Childhood cardiovascular risk factors and adult cardiovascular events
Yazar:: Jacobs, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Composition for preventing cardiovascular diseases
Yazar:: Ismail, Maznah, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Polypill for cardiovascular disease prevention.
Yazar:: Dalton, A
Baskı/Yayın Bilgisi: (2013)

Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention
Yazar:: Mundra, PA, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Formulation And Evaluation Of Palm Oil Esters Based Nanoemulsion For Topical Delivery Of Ketoprofen
Yazar:: Sakeena, Mohamed Hameem Fatima
Baskı/Yayın Bilgisi: (2010)

The bisphosphonate-ester apornine does not act by inhibiting protein prenylation, but enhances the effects of lovastatin on myeloma cells
Yazar:: Roelofs, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
Yazar:: Collaboration, B
Baskı/Yayın Bilgisi: (2006)

Aspirin for prevention of cancer and cardiovascular disease.
Yazar:: Rose, P, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

An approach to enzyme inhibition employing reversible boronate ester formation
Yazar:: Leung, I, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Antiplatelet therapy use for the secondary prevention of cardiovascular disease in 2009-2017: a population-wide retrospective cohort study of Scotland
Yazar:: Thalmann, I, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland
Yazar:: Thalmann, I, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Cardiovascular events after intracerebral hemorrhage
Yazar:: Li, L, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Formation of palm kernel oil esters nanoemulsion systems containing ibuprofen for topical delivery
Yazar:: Salim, Norazlinaliza
Baskı/Yayın Bilgisi: (2013)

Cardiovascular risk scoring for the prevention of cardiovascular disease in low-resource settings
Yazar:: Collins, DRJ
Baskı/Yayın Bilgisi: (2017)

Topic modelling of authentication events in an enterprise computer network
Yazar:: Heard, N, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Your baby's first year week by week /
Yazar:: 300181 Curtis, Glade B., ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Beyond ten-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
Yazar:: Kohli-Lynch, CN, ve diğerleri
Baskı/Yayın Bilgisi: (2022)